Role of brain-derived neurotrophic factor in Huntington's disease
The DOI matches its Crossref record; 341 of the 341 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 5×
“The BDNF Val66Met polymorphism is highly conserved across species and relatively common in the human population with a prevalence for heterozygotes of 20–30%, and a prevalence for the homozygote of $4% (Neves-Pereira et al., 2002; Egan et al., 2003; Hariri et al., 2003; Sen et al., 2003).”
BackgroundInfluentialNestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Neurotrophins and their receptors: A convergence point for many signalling pathways
Chao, M. V. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1078 · Cited by 2,298 · cited 1×
“…and autocrine manner to control a variety of brain processes, including the growth, development, differentiation and maintenance of neuronal systems, neuronal plasticity, synaptic activity and neurotransmitter-mediated activities (see Chao, 2003, and Binder and Scharfman, 2004, for reviews).”
BackgroundPurification of a new neurotrophic factor from mammalian brain.
Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822 · cited 1×
“BDNF was discovered in 1982 (Barde et al., 1982), as the second in a family of molecules with neurotrophic activities whose first identified member was nerve growth factor (NGF) (Levi-Montalcini and Hamburger, 1951).”
BackgroundGaliègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Regulation of Cell Survival by Secreted Proneurotrophins
Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001) · Science · doi:10.1126/science.1065057 · Cited by 1,670
Saudou, F., Finkbeiner, S., Devys, D., & Greenberg, M. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81782-1 · Cited by 1,595
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Binder (2004) · doi:10.1080/08977190410001723308 · Cited by 1,481
Molecular cloning and expression of brain-derived neurotrophic factor
Leibrock, J., Lottspeich, F., Hohn, A., Hofer, M., Hengerer, B., Masiakowski, P., Thoenen, H., & Barde, Y.-A. (1989) · Nature · doi:10.1038/341149a0 · Cited by 1,457
DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
Chen, R. Z., Akbarian, S., Tudor, M., & Jaenisch, R. (2001) · Nature Genetics · doi:10.1038/85906 · Cited by 1,275 · cited 2×
“Mutations in the MeCP2 gene are the cause of Rett's syndrome (RTT), an X-linked progressive disorder characterised by arrested neurological development and subsequent cognitive decline.”
BackgroundDerepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232
Maisonpierre, P. C., Belluscio, L., Friedman, B., Alderson, R. F., Wiegand, S. J., Furth, M. E., Lindsay, R. M., & Yancopoulos, G. D. (1990) · Neuron · doi:10.1016/0896-6273(90)90089-x · Cited by 1,231
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B. L., Kazantsev, A., Schmidt, E., Zhu, Y.-Z., Greenwald, M., et al. (2001) · Nature · doi:10.1038/35099568 · Cited by 1,228 · cited 3×
“They also found that a reduction in the acetyltransferase activity of CBP causes a reduction in histone acetylation (Steffan et al., 2001), thus leading to a more compact chromatin structure that is less accessible to transcription factors, and potentially explaining the decrease in CRE-dependent…”
BackgroundInfluentialCB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208 · cited 1×
“More importantly, it has been demonstrated that the activation of these receptors increases the amount of BDNF released from the presynaptic terminals (Marsicano et al., 2003).”
BackgroundNibuya, M., Nestler, E., & Duman, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02365.1996 · Cited by 1,206
Gauthier, L. R., Charrin, B. C., Borrell-Pagès, M., Dompierre, J. P., Rangone, H., Cordelières, F. P., De Mey, J., MacDonald, M. E., Leßmann, V., Humbert, S., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.018 · Cited by 1,178 · cited 22×
“It was found that wildtype huntingtin enhances BDNF transport to both the tips of the neurite and the cell body, suggesting a possible role for huntingtin in both the anterograde and retrograde transport of BDNF (Gauthier et al., 2004).”
BackgroundMethodResultInfluentialHohn, A., Leibrock, J., Bailey, K., & Barde, Y.-A. (1990) · Nature · doi:10.1038/344339a0 · Cited by 1,145 · cited 2×
“Its primary amino acid sequence reveals the presence of a signal peptide following the initiation codon (Leibrock et al., 1989; Ernfors et al., 1990; Hohn et al., 1990; Jones and Reichardt, 1990; Kaisho et al., 1990; Rosenthal et al., 1990; Maisonpierre et al., 1990; Berkemeier et al., 1991;…”
BackgroundAndrew, S. E., Paul Goldberg, Y., Kremer, B., Telenius, H., Theilmann, J., Adam, S., Starr, E., Squitieri, F., Lin, B., Kalchman, M. A., et al. (1993) · Nature Genetics · doi:10.1038/ng0893-398 · Cited by 1,129
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease
Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., et al. (2001) · Science · doi:10.1126/science.1059581 · Cited by 1,123
Self-citationConner, J. M., Lauterborn, J. C., Yan, Q., Gall, C. M., & Varon, S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02295.1997 · Cited by 1,097 · cited 5×
“BDNF immunoreactivity (Dugich-Djordjevic et al., 1995; Kawamoto et al., 1996, 1999; Conner et al., 1997; Yan et al., 1997; Furukawa et al., 1998) and BDNF mRNA expression have also been observed in mammalian nigral dopaminergic neurons projecting to striatal targets (Wetmore et al.”
BackgroundResultInfluentialNucifora, F. C., Sasaki, M., Peters, M. F., Huang, H., Cooper, J. K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V. L., et al. (2001) · Science · doi:10.1126/science.1056784 · Cited by 1,094
Trinucleotide repeat length instability and age of onset in Huntington's disease
Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., et al. (1993) · Nature Genetics · doi:10.1038/ng0893-387 · Cited by 1,089 · cited 2×
“…was hypothesised that familial factors other than CAG repeats may account for a proportion of the variance in the age of onset (Andrew et al., 1993; Duyao et al., 1993; Snell et al., 1993), and the search for genetic modifiers of HD onset and progression represents a major part of current HD…”
BackgroundHariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06690.2003 · Cited by 1,045 · cited 2×
“The BDNF Val66Met polymorphism is highly conserved across species and relatively common in the human population with a prevalence for heterozygotes of 20–30%, and a prevalence for the homozygote of !4% (Neves-Pereira et al., 2002; Egan et al., 2003; Hariri et al., 2003; Sen et al., 2003).”
BackgroundRegional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain.
Hofer, M., Pagliusi, S. R., Hohn, A., Leibrock, J., & Barde, Y. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07423.x · Cited by 1,017
ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75NTRand Sortilin
Teng, H. K., Teng, K. K., Lee, R., Wright, S., Tevar, S., Almeida, R. D., Kermani, P., Torkin, R., Chen, Z.-Y., Lee, F. S., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5123-04.2005 · Cited by 1,013 · cited 4×
“Novel findings indicate that the 32 kDa pro- BDNF form may also be extracellularly active at the synaptic terminals, activating intracellular pathways other than mature BDNF (Lee et al., 2001; Woo et al., 2005) and promoting apoptotic cell death (Teng et al., 2005).”
BackgroundInfluentialHuntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B. R., Hayden, M. R., Timmusk, T., et al. (2003) · Nature Genetics · doi:10.1038/ng1219 · Cited by 979 · cited 22×
“…cerebellum of R6/2 mice (Luthi-Carter et al., 2002) 2003 BDNF mRNA is progressively reduced in Hdh 7/7 , Hdh 109/7 and Hdh 109/109 knock in cells (Zuccato et al., 2003) Cortical and striatal BDNF protein levels are reduced in transgenic HD mice (N-171 82Q) (Duan et al., 2003) Reduced BDNF…”
BackgroundInfluentialSelf-citationSchoenherr, C. J., & Anderson, D. J. (1995) · Science · doi:10.1126/science.7871435 · Cited by 976
REST: A mammalian silencer protein that restricts sodium channel gene expression to neurons
Chong, J. A., Tapia-Ramirez, J., Kim, S., Toledo-Aral, J. J., Zheng, Y., Boutros, M. C., Altshuller, Y. M., Frohman, M. A., Kraner, S. D., & Mandel, G. (1995) · Cell · doi:10.1016/0092-8674(95)90298-8 · Cited by 967
Levi‐Montalcini, R., & Hamburger, V. (1951) · Journal of Experimental Zoology · doi:10.1002/jez.1401160206 · Cited by 955
REST and Its Corepressors Mediate Plasticity of Neuronal Gene Chromatin throughout Neurogenesis
Ballas, N., Grunseich, C., Lu, D. D., Speh, J. C., & Mandel, G. (2005) · Cell · doi:10.1016/j.cell.2005.03.013 · Cited by 950
BDNF and Activity-Dependent Synaptic Modulation: Figure 1.
Lu, B. (2003) · Learning & Memory · doi:10.1101/lm.54603 · Cited by 945
Mouse and rat BDNF gene structure and expression revisited
Aid, T., Kazantseva, A., Piirsoo, M., Palm, K., & Timmusk, T. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21139 · Cited by 943
Zafra, F., Hengerer, B., Leibrock, J., Thoenen, H., & Lindholm, D. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07564.x · Cited by 897 · cited 1×
“Early studies indicated that BDNF promoter I is physiologically activated at low levels and stimulated by the administration of KA, which evokes calcium signals through different subtypes of glutamate receptors (Zafra et al., 1990; Metsis et al., 1993).”
BackgroundAnterograde transport of brain-derived neurotrophic factor and its role in the brain
Altar, C. A., Cai, N., Bliven, T., Juhasz, M., Conner, J. M., Acheson, A. L., Lindsay, R. M., & Wiegand, S. J. (1997) · Nature · doi:10.1038/39885 · Cited by 879
Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874 · cited 7×
“Interestingly, phylogeny and gene mapping data of the neurotrophin and TrkB receptor gene families suggest that they both date back at least 460 million years to the early vertebrates (Hallbook, 1999; see Murer et al., 2001 for a review).”
BackgroundResultInfluentialChen, Z.-Y., Patel, P. D., Sant, G., Meng, C.-X., Teng, K. K., Hempstead, B. L., & Lee, F. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0348-04.2004 · Cited by 874 · cited 1×
“This BDNF polymorphism does not affect mature BDNF protein function, but it has recently been shown that it dramatically alters the intracellular trafficking and packaging of pro-BDNF, and consequently the regulated secretion of the mature peptide (Egan et al., 2003; Chen et al., 2004).”
BackgroundMultiple promoters direct tissue-specific expression of the rat BDNF gene
Timmusk, T., Palm, K., Metsis, M., Reintam, T., Paalme, V., Saarma, M., & Persson, H. (1993) · Neuron · doi:10.1016/0896-6273(93)90335-o · Cited by 858 · cited 10×
“BDNF exon nomenclature is according to Timmusk et al., 1993.”
BackgroundMethodInfluentialDifferential loss of striatal projection neurons in Huntington disease.
Reiner, A., Albin, R. L., Anderson, K. D., D'Amato, C. J., Penney, J. B., & Young, A. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5733 · Cited by 839
Neurotrophin-5: A novel neurotrophic factor that activates trk and trkB
Berkemeier, L. R., Winslow, J. W., Kaplan, D. R., Nikolics, K., Goeddel, D. V., & Rosenthal, A. (1991) · Neuron · doi:10.1016/0896-6273(91)90287-a · Cited by 836
Hallböök, F., Ibáñez, C. F., & Persson, H. (1991) · Neuron · doi:10.1016/0896-6273(91)90180-8 · Cited by 834
Hodgson, J. G., Agopyan, N., Gutekunst, C.-A., Leavitt, B. R., LePiane, F., Singaraja, R., Smith, D. J., Bissada, N., McCutcheon, K., Nasir, J., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80764-3 · Cited by 830
Activation of p75NTR by proBDNF facilitates hippocampal long-term depression
Woo, N. H., Teng, H. K., Siao, C.-J., Chiaruttini, C., Pang, P. T., Milner, T. A., Hempstead, B. L., & Lu, B. (2005) · Nature Neuroscience · doi:10.1038/nn1510 · Cited by 815 · cited 4×
“Novel findings indicate that the 32 kDa pro- BDNF form may also be extracellularly active at the synaptic terminals, activating intracellular pathways other than mature BDNF (Lee et al., 2001; Woo et al., 2005) and promoting apoptotic cell death (Teng et al., 2005).”
BackgroundInfluentialThe U.S.–Venezuela Collaborative Research Project*, & Wexler, N. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308679101 · Cited by 761
Transcription and Processing of Human microRNA Precursors
Cullen, B. R. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.12.002 · Cited by 759
Schilling, G. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.397 · Cited by 753
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749 · cited 4×
“Huntingtin is predominantly found in the cytoplasm of neurons and is enriched in compartments containing vesicleassociated proteins (DiFiglia et al., 1995).”
BackgroundInfluentialReciprocal actions of REST and a microRNA promote neuronal identity
Conaco, C., Otto, S., Han, J.-J., & Mandel, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511041103 · Cited by 736 · cited 3×
“In neurons, where the levels of REST/NRSF are lower, the miR-124a gene is transcribed, thus leading to the downregulation of nonneuronal transcripts in favour of a neuronal phenotype (Conaco et al., 2006).”
BackgroundInfluentialEnvironmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective
Young, D., Lawlor, P. A., Leone, P., Dragunow, M., & During, M. J. (1999) · Nature Medicine · doi:10.1038/7449 · Cited by 732
The neurotrophin hypothesis for synaptic plasticity
Schinder, A. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01672-6 · Cited by 728
Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease
Snell, R. G., MacMillan, J. C., Cheadle, J. P., Fenton, I., Lazarou, L. P., Davies, P., MacDonald, M. E., Gusella, J. F., Harper, P. S., & Shaw, D. J. (1993) · Nature Genetics · doi:10.1038/ng0893-393 · Cited by 709
Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease
Dunah, A. W., Jeong, H., Griffin, A., Kim, Y.-M., Standaert, D. G., Hersch, S. M., Mouradian, M. M., Young, A. B., Tanese, N., & Krainc, D. (2002) · Science · doi:10.1126/science.1072613 · Cited by 708
Ernfors, P., Ibáñez, C. F., Ebendal, T., Olson, L., & Persson, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5454 · Cited by 700 · cited 2×
“Its primary amino acid sequence reveals the presence of a signal peptide following the initiation codon (Leibrock et al., 1989; Ernfors et al., 1990; Hohn et al., 1990; Jones and Reichardt, 1990; Kaisho et al., 1990; Rosenthal et al., 1990; Maisonpierre et al., 1990; Berkemeier et al., 1991;…”
BackgroundIdentification of a Signaling Pathway Involved in Calcium Regulation of BDNF Expression
Shieh, P. B., Hu, S.-C., Bobb, K., Timmusk, T., & Ghosh, A. (1998) · Neuron · doi:10.1016/s0896-6273(00)81011-9 · Cited by 693 · cited 2×
“These regulatory elements are stimulated by Ca 2+ signals evoked by N-methyl-D-aspartate glutamate receptor (NMDA-R) and involve cyclic adenosine 3 0 ,5 0 monophosphate (cAMP) responsive element (CRE) binding protein (CREB), together with CaM kinase IV (Shieh et al., 1998; Tao et al., 1998).”
BackgroundMolecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 687
Normal huntingtin function: an alternative approach to Huntington's disease
Cattaneo, E., Zuccato, C., & Tartari, M. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1806 · Cited by 657
Self-citationGunawardena, S., Her, L.-S., Brusch, R. G., Laymon, R. A., Niesman, I. R., Gordesky-Gold, B., Sintasath, L., Bonini, N. M., & Goldstein, L. S. B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00594-4 · Cited by 646
Ip, N. Y., Ibáñez, C. F., Nye, S. H., McClain, J., Jones, P. F., Gies, D. R., Belluscio, L., Le Beau, M. M., Espinosa, R., & Squinto, S. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3060 · Cited by 626 · cited 2×
“…Jones and Reichardt, 1990; Kaisho et al., 1990; Rosenthal et al., 1990; Maisonpierre et al., 1990; Berkemeier et al., 1991; Hallbook et al., 1991; Ip et al., 1992), and a pro-region including a N-terminal glycosylation site and a proteolytic cleavage site (Bresnahan et al., 1990; Seidah et al.,…”
BackgroundPoduslo, J. F., & Curran, G. L. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00250-v · Cited by 614 · cited 1×
“Unfortunately, neurotrophins have a number of suboptimal pharmacological properties, including poor stability with a serum half-life of minutes or less, poor oral bioavailability, and restricted CNS penetration (Poduslo and Curran, 1996; Saltzman et al., 1999; Pardridge, 2002).”
BackgroundDominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells
Trettel, F. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2799 · Cited by 610
A huntingtin-associated protein enriched in brain with implications for pathology
Li, X.-J., Li, S.-H., Sharp, A. H., Nucifora, F. C., Schilling, G., Lanahan, A., Worley, P., Snyder, S. H., & Ross, C. A. (1995) · Nature · doi:10.1038/378398a0 · Cited by 601
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 595
Neves-Pereira, M., Mundo, E., Muglia, P., King, N., Macciardi, F., & Kennedy, J. L. (2002) · The American Journal of Human Genetics · doi:10.1086/342288 · Cited by 594
Brain-derived neurotrophic factor is reduced in Alzheimer's disease
Connor, B., Young, D., Yan, Q., Faull, R. L. M., Synek, B., & Dragunow, M. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00125-3 · Cited by 581
Batchelor, P. E., Liberatore, G. T., Wong, J. Y. F., Porritt, M. J., Frerichs, F., Donnan, G. A., & Howells, D. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-05-01708.1999 · Cited by 578
Dragatsis, I., Levine, M. S., & Zeitlin, S. (2000) · Nature Genetics · doi:10.1038/81593 · Cited by 576
Sklar, P., Gabriel, S. B., McInnis, M. G., Bennett, P., Lim, Y.-M., Tsan, G., Schaffner, S., Kirov, G., Jones, I., Owen, M., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001058 · Cited by 567
Synapsins as mediators of BDNF-enhanced neurotransmitter release
Jovanovic, J. N., Czernik, A. J., Fienberg, A. A., Greengard, P., & Sihra, T. S. (2000) · Nature Neuroscience · doi:10.1038/73888 · Cited by 566
Primary structure and biological activity of a novel human neurotrophic factor
Rosenthal, A., Goeddel, D. V., Nguyen, T., Lewis, M., Shih, A., Laramee, G. R., Nikolics, K., & Winslow, J. W. (1990) · Neuron · doi:10.1016/0896-6273(90)90203-r · Cited by 556
CREB-binding protein sequestration by expanded polyglutamine
McCampbell, A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.14.2197 · Cited by 548
Transcriptional abnormalities in Huntington disease
Sugars, K. L., & Rubinsztein, D. C. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00074-x · Cited by 529
Novel roles for neurotrophins are suggested by BDNF and NT-3 mRNA expression in developing neurons
Schecterson, L. C., & Bothwell, M. (1992) · Neuron · doi:10.1016/0896-6273(92)90183-e · Cited by 521
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro
Trushina, E., Dyer, R. B., Badger, J. D., Ure, D., Eide, L., Tran, D. D., Vrieze, B. T., Legendre-Guillemin, V., McPherson, P. S., Mandavilli, B. S., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.8195-8209.2004 · Cited by 520 · cited 2×
“However, this is in conflict with the results of Trushina et al. (2004), who found that mitochondria transport was specifically affected in cells depleted of endogenous huntingtin and in cells bearing mutant huntingtin.”
BackgroundResultMichael, G. J., Averill, S., Nitkunan, A., Rattray, M., Bennett, D. L. H., Yan, Q., & Priestley, J. V. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08476.1997 · Cited by 512
Maisonpierre, P. C., Le Beau, M. M., Espinosa, R., Ip, N. Y., Belluscio, L., de la Monte, S. M., Squinto, S., Furth, M. E., & Yancopoulos, G. D. (1991) · Genomics · doi:10.1016/0888-7543(91)90436-i · Cited by 512
Delaying the onset of Huntington's in mice
van Dellen, A., Blakemore, C., Deacon, R., York, D., & Hannan, A. J. (2000) · Nature · doi:10.1038/35008142 · Cited by 511
Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis
Rosas, H. D., Koroshetz, W. J., Chen, Y. I., Skeuse, C., Vangel, M., Cudkowicz, M. E., Caplan, K., Marek, K., Seidman, L. J., Makris, N., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000065888.88988.6e · Cited by 505
New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor
McDonald, N. Q., Lapatto, R., Rust, J. M., Gunning, J., Wlodawer, A., & Blundell, T. L. (1991) · Nature · doi:10.1038/354411a0 · Cited by 502
Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system
Yan, Q., Rosenfeld, R. D., Matheson, C. R., Hawkins, N., Lopez, O. T., Bennett, L., & Welcher, A. A. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00613-6 · Cited by 500
CoREST: A functional corepressor required for regulation of neural-specific gene expression
Andrés, M. E., Burger, C., Peral-Rubio, M. J., Battaglioli, E., Anderson, M. E., Grimes, J., Dallman, J., Ballas, N., & Mandel, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9873 · Cited by 494 · cited 2×
“…co-repressors, including the mammalian homologue of yeast Sin3A (mSin3A) (Huang et al., 1999; Roopra et al., 2000) and REST co-repressor (CoREST) (Andres et al., 1999; Ballas et al., 2001), which in turn recruit multiple cofactors and transcriptional regulators, including brahma-related gene 1…”
BackgroundBruce, A. W., Donaldson, I. J., Wood, I. C., Yerbury, S. A., Sadowski, M. I., Chapman, M., Göttgens, B., & Buckley, N. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401827101 · Cited by 485 · cited 4×
“uk/ RE1db_mkII/), most of which encode for ion channels, neurotransmitters, growth factors and hormones, factors involved in axonal guidance and vesicle trafficking, and molecules involved in maintaining the cytoskeleton and extracellular matrix (Bruce et al., 2004).”
BackgroundInfluentialNRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis
Chen, Z.-F., Paquette, A. J., & Anderson, D. J. (1998) · Nature Genetics · doi:10.1038/2431 · Cited by 460
Lee, J., Seroogy, K. B., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00747.x · Cited by 455
BDNF and epilepsy: too much of a good thing?
Binder, D. K., Croll, S. D., Gall, C. M., & Scharfman, H. E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01682-9 · Cited by 454
A controlled trial of recombinant methionyl human BDNF in ALS
The BDNF Study Group (Phase III) (1999) · Neurology · doi:10.1212/wnl.52.7.1427 · Cited by 451
A small modulatory dsRNA specifies the fate of adult neural stem cells
Kuwabara, T., Hsieh, J., Nakashima, K., Taira, K., & Gage, F. H. (2004) · Cell · doi:10.1016/s0092-8674(04)00248-x · Cited by 447
Duan, W., Guo, Z., Jiang, H., Ware, M., Li, X.-J., & Mattson, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536856100 · Cited by 428 · cited 6×
“An additional study by Duan et al. (2003) found that BDNF protein levels were significantly decreased by 70–80% in the striatum and cortex of 3-month-old HD mice expressing a 517 amino acid N-terminal portion of huntingtin with 82 polyglutamine repeats driven by a mouse prion protein promoter…”
BackgroundInfluentialMori, N., Schoenherr, C., Vandenbergh, D. J., & Anderson, D. J. (1992) · Neuron · doi:10.1016/0896-6273(92)90219-4 · Cited by 418
Regulation of Neuronal Traits by a Novel Transcriptional Complex
Ballas, N., Battaglioli, E., Atouf, F., Andres, M. E., Chenoweth, J., Anderson, M. E., Burger, C., Moniwa, M., Davie, J. R., Bowers, W. J., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00371-3 · Cited by 417
Baquet, Z. C., Gorski, J. A., & Jones, K. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3920-03.2004 · Cited by 414
Ferrer, I., Marín, C., Rey, M. J., Ribalta, T., Goutan, E., Blanco, R., Tolosa, E., & Martí, E. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199907000-00007 · Cited by 407
Identification of potential target genes for the neuron-restrictive silencer factor.
Schoenherr, C. J., Paquette, A. J., & Anderson, D. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9881 · Cited by 406
Wild-Type Huntingtin Protects from Apoptosis Upstream of Caspase-3
Rigamonti, D., Bauer, J. H., De-Fraja, C., Conti, L., Sipione, S., Sciorati, C., Clementi, E., Hackam, A., Hayden, M. R., Li, Y., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03705.2000 · Cited by 405
Self-citationMolecular cloning of a human gene that is a member of the nerve growth factor family.
Jones, K. R., & Reichardt, L. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.20.8060 · Cited by 404
Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes
Huang, Y., Myers, S. J., & Dingledine, R. (1999) · Nature Neuroscience · doi:10.1038/13165 · Cited by 396
Falkenberg, T., Mohammed, A. K., Henriksson, B., Persson, H., Winblad, B., & Lindefors, N. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90494-r · Cited by 388
Inhibition of GABAASynaptic Responses by Brain-Derived Neurotrophic Factor (BDNF) in Rat Hippocampus
Tanaka, T., Saito, H., & Matsuki, N. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-09-02959.1997 · Cited by 385 · cited 2×
“…transmission by acting in an autocrine manner to stimulate glutamate release from cortical projection neurons (Jovanovic et al., 2000; Schinder and Poo, 2000) and inhibiting GABAergic synaptic transmission at the postsynapse (Tanaka et al., 1997; Frerking et al., 1998; Wardle and Poo, 2003).”
BackgroundHuman fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo.
Bresnahan, P. A., Leduc, R., Thomas, L., Thorner, J., Gibson, H. L., Brake, A. J., Barr, P. J., & Thomas, G. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.6.2851 · Cited by 383
Karpuj, M. V., Becher, M. W., Springer, J. E., Chabas, D., Youssef, S., Pedotti, R., Mitchell, D., & Steinman, L. (2002) · Nature Medicine · doi:10.1038/nm0202-143 · Cited by 379
Fukumoto, T., Morinobu, S., Okamoto, Y., Kagaya, A., & Yamawaki, S. (2001) · Psychopharmacology · doi:10.1007/s002130100871 · Cited by 376
Neuronal Expression of Zinc Finger Transcription Factor REST/NRSF/XBR Gene
Palm, K., Belluardo, N., Metsis, M., & Timmusk, T. Õ. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-04-01280.1998 · Cited by 371
Wetmore, C., Ernfors, P., Persson, H., & Olson, L. (1990) · Experimental Neurology · doi:10.1016/0014-4886(90)90068-4 · Cited by 367
Luthi-Carter, R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.1911 · Cited by 367
Spires, T. L., Grote, H. E., Varshney, N. K., Cordery, P. M., van Dellen, A., Blakemore, C., & Hannan, A. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1658-03.2004 · Cited by 365
Igarashi, S., Koide, R., Shimohata, T., Yamada, M., Hayashi, Y., Takano, H., Date, H., Oyake, M., Sato, T., Sato, A., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-111 · Cited by 355
Mowla, S. J., Pareek, S., Farhadi, H. F., Petrecca, K., Fawcett, J. P., Seidah, N. G., Morris, S. J., Sossin, W. S., & Murphy, R. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-06-02069.1999 · Cited by 350
Radka, S. F., Hoist, P. A., Fritsche, M., & Altar, C. A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01321-0 · Cited by 348
Canals, J. M., Pineda, J. R., Torres-Peraza, J. F., Bosch, M., Martín-Ibañez, R., Muñoz, M. T., Mengod, G., Ernfors, P., & Alberch, J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1197-04.2004 · Cited by 345
Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin
Engelender, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.13.2205 · Cited by 341
Interaction of Huntington Disease Protein with Transcriptional Activator Sp1
Li, S.-H., Cheng, A. L., Zhou, H., Lam, S., Rao, M., Li, H., & Li, X.-J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1277-1287.2002 · Cited by 340
Sen, S., Nesse, R. M., Stoltenberg, S. F., Li, S., Gleiberman, L., Chakravarti, A., Weder, A. B., & Burmeister, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300053 · Cited by 332
Brain-derived neurotrophic factor in Huntington disease
Ferrer, I., Goutan, E., Marı́n, C., Rey, M. J., & Ribalta, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02237-x · Cited by 331
Environmental enrichment slows disease progression in R6/2 Huntington's disease mice
Hockly, E., Cordery, P. M., Woodman, B., Mahal, A., Van Dellen, A., Blakemore, C., Lewis, C. M., Hannan, A. J., & Bates, G. P. (2002) · Annals of Neurology · doi:10.1002/ana.10094 · Cited by 330
Goodman, L. J., Valverde, J., Lim, F., Geschwind, M. D., Federoff, H. J., Geller, A. I., & Hefti, F. (1996) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1996.0017 · Cited by 323
Cepeda, C., Hurst, R. S., Calvert, C. R., Hernández-Echeagaray, E., Nguyen, O. K., Jocoy, E., Christian, L. J., Ariano, M. A., & Levine, M. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00961.2003 · Cited by 321
Neurotrophin trafficking by anterograde transport
Altar, C. A., & DiStefano, P. S. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01273-9 · Cited by 319
Blöchl, A., & Thoenen, H. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01112.x · Cited by 319
Therapeutic Effects of Cystamine in a Murine Model of Huntington's Disease
Dedeoglu, A., Kubilus, J. K., Jeitner, T. M., Matson, S. A., Bogdanov, M., Kowall, N. W., Matson, W. R., Cooper, A. J. L., Ratan, R. R., Beal, M. F., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08942.2002 · Cited by 316
Ischemic Insults Derepress the Gene Silencer REST in Neurons Destined to Die
Calderone, A., Jover, T., Noh, K.-M., Tanaka, H., Yokota, H., Lin, Y., Grooms, S. Y., Regis, R., Bennett, M. V. L., & Zukin, R. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02112.2003 · Cited by 311
Regional cortical thinning in preclinical Huntington disease and its relationship to cognition
Rosas, H. D., Hevelone, N. D., Zaleta, A. K., Greve, D. N., Salat, D. H., & Fischl, B. (2005) · Neurology · doi:10.1212/01.wnl.0000174432.87383.87 · Cited by 309
Sorting and processing of secretory proteins
Halban, P. A., & Irminger, J. C. (1994) · Biochemical Journal · doi:10.1042/bj2990001 · Cited by 307
Katoh‐Semba, R., Takeuchi, I. K., Semba, R., & Kato, K. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010034.x · Cited by 307
Tardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.7 · Cited by 303 · cited 3×
“Serotonin may have protective effects on striatal and cortical neurons by activating cyclic AMP and CREB signals, which also lead to BDNF expression; other target genes of cyclic AMP-CREB signalling that may play a role in the neuroprotective effect of SSRIs include Bcl-2 and NFKB (Freeland et al., 2001; Tardito et al…”
BackgroundOchs, G., Penn, R. D., York, M., Giess, R., Beck, M., Tonn, J., Haigh, J., Malta, E., Traub, M., Sendtner, M., et al. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515197 · Cited by 302 · cited 1×
“It is probably for these reasons that subcutaneous and intrathecal BDNF administrations have met with little clinical success (BDNF study group Phase III, 1999; Ochs et al., 2000).”
BackgroundA core–BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes
Hakimi, M.-A., Bochar, D. A., Chenoweth, J., Lane, W. S., Mandel, G., & Shiekhattar, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112008599 · Cited by 298
Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine
Liu, Q.-R., Lu, L., Zhu, X.-G., Gong, J.-P., Shaham, Y., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.10.004 · Cited by 297
Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases
SEIDAH, N. G., BENJANNET, S., PAREEK, S., SAVARIA, D., HAMELIN, J., GOULET, B., LALIBERTÉ, J., LAZURE, C., CHRÉTIEN, M., & MURPHY, R. A. (1996) · Biochemical Journal · doi:10.1042/bj3140951 · Cited by 291
Dubey, A., Forster, M. J., Lal, H., & Sohal, R. S. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0380 · Cited by 289
Mattson, M. P., Duan, W., & Guo, Z. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01586.x · Cited by 288
Kegel, K. B., Meloni, A. R., Yi, Y., Kim, Y. J., Doyle, E., Cuiffo, B. G., Sapp, E., Wang, Y., Qin, Z.-H., Chen, J. D., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103946200 · Cited by 287
Westlake, T. M., Howlett, A. C., Bonner, T. I., Matsuda, L. A., & Herkenham, M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90511-8 · Cited by 283
Interaction of Huntingtin-associated Protein-1 with Kinesin Light Chain
McGuire, J. R., Rong, J., Li, S.-H., & Li, X.-J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509806200 · Cited by 281
Hall, D., Dhilla, A., Charalambous, A., Gogos, J. A., & Karayiorgou, M. (2003) · The American Journal of Human Genetics · doi:10.1086/377003 · Cited by 277
Knusel, B., Beck, K., Winslow, J., Rosenthal, A., Burton, L., Widmer, H., Nikolics, K., & Hefti, F. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04391.1992 · Cited by 276
Gines, S. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg046 · Cited by 276
Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation
Schaaf, M. J. M., De Kloet, E. R., & Vreugdenhil, E. (2000) · Stress · doi:10.3109/10253890009001124 · Cited by 270 · cited 1×
“Unlike the other BDNF promoters analysed above, BDNF exon IV promoter contains glucocorticoid-responsive elements (Schaaf et al., 2000, for a review), and its activity is influenced by thyroid hormone (Koibuchi et al., 1999) and corticosterone (Hansson et al., 2006).”
BackgroundInteraction of Huntingtin-Associated Protein with Dynactin P150Glued
Li, S.-H., Gutekunst, C.-A., Hersch, S. M., & Li, X.-J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-04-01261.1998 · Cited by 270
Neurotrophin secretion from cultured microglia
Nakajima, K., Honda, S., Tohyama, Y., Imai, Y., Kohsaka, S., & Kurihara, T. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1157 · Cited by 267
Pang, T. Y. C., Stam, N. C., Nithianantharajah, J., Howard, M. L., & Hannan, A. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.04.013 · Cited by 265
Ventimiglia, R., Mather, P. E., Jones, B. E., & Lindsay, R. M. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01057.x · Cited by 263
Pham, T. M., Ickes, B., Albeck, D., Söderström, S., Granholm, A.-C., & Mohammed, A. H. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00316-4 · Cited by 262
BDNF gene is a risk factor for schizophrenia in a Scottish population
Neves-Pereira, M., Cheung, J. K., Pasdar, A., Zhang, F., Breen, G., Yates, P., Sinclair, M., Crombie, C., Walker, N., & St Clair, D. M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001575 · Cited by 262
Frisén, J., Verge, V. M., Fried, K., Risling, M., Persson, H., Trotter, J., Hökfelt, T., & Lindholm, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4971 · Cited by 259
Velier, J., Kim, M., Schwarz, C., Kim, T. W., Sapp, E., Chase, K., Aronin, N., & DiFiglia, M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6832 · Cited by 258
Brain-Derived Neurotrophic Factor Promotes Differentiation of Striatal GABAergic Neurons
Mizuno, K., Carnahan, J., & Nawa, H. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1250 · Cited by 255
Metsis, M., Timmusk, T., Arenas, E., & Persson, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8802 · Cited by 248
Dopamine Modulates Release from Corticostriatal Terminals
Bamford, N. S., Robinson, S., Palmiter, R. D., Joyce, J. A., Moore, C., & Meshul, C. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2891-04.2004 · Cited by 238
Rubinsztein, D. C., Leggo, J., Chiano, M., Dodge, A., Norbury, G., Rosser, E., & Craufurd, D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3872 · Cited by 238
Borrell-Pages, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27607 · Cited by 236
Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease
Ventriglia, M., Bocchio Chiavetto, L., Benussi, L., Binetti, G., Zanetti, O., Riva, M. A., & Gennarelli, M. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000952 · Cited by 235
Bloch, J., Bachoud-Lévi, A. C., Déglon, N., Lefaucheur, J. P., Winkel, L., Palfi, S., Nguyen, J. P., Bourdet, C., Remy, P., Brugières, P., et al. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.968 · Cited by 231
Dynein motors transport activated Trks to promote survival of target-dependent neurons
Heerssen, H. M., Pazyra, M. F., & Segal, R. A. (2004) · Nature Neuroscience · doi:10.1038/nn1242 · Cited by 228
Hermel, E., Gafni, J., Propp, S. S., Leavitt, B. R., Wellington, C. L., Young, J. E., Hackam, A. S., Logvinova, A. V., Peel, A. L., Chen, S. F., et al. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401358 · Cited by 226
Liu, Q., Walther, D., Drgon, T., Polesskaya, O., Lesnick, T. G., Strain, K. J., de Andrade, M., Bower, J. H., Maraganore, D. M., & Uhl, G. R. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30109 · Cited by 226
Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles
Hilditch-Maguire, P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2789 · Cited by 226 · cited 2×
“It is associated with various organelles, including the nucleus, endoplasmic reticulum and Golgi complex (DiFiglia et al., 1995; Velier et al., 1998; Hilditch-Maguire et al., 2000; Hoffner et al., 2002; Kegel et al., 2002), and is also found in neurites and at synapses, where it associates with vesicular structures su…”
BackgroundMaue, R. A., Kraner, S. D., Goodman, R. H., & Mandelt, G. (1990) · Neuron · doi:10.1016/0896-6273(90)90097-y · Cited by 225
Gu, X., Li, C., Wei, W., Lo, V., Gong, S., Li, S.-H., Iwasato, T., Itohara, S., Li, X.-J., Mody, I., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.025 · Cited by 221
Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice
Gorski, J. A., Balogh, S. A., Wehner, J. M., & Jones, K. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00426-3 · Cited by 218
Martı́nez-Serrano, A., & Björklund, A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-15-04604.1996 · Cited by 214
Roopra, A., Sharling, L., Wood, I. C., Briggs, T., Bachfischer, U., Paquette, A. J., & Buckley, N. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2147-2157.2000 · Cited by 210
Tabuchi, A., Sakaya, H., Kisukeda, T., Fushiki, H., & Tsuda, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204784200 · Cited by 209
Regulation of Neuropeptides in Adult Rat Forebrain by the Neurotrophins BDNF and NGF
Croll, S. D., Wiegand, S. J., Anderson, K. D., Lindsay, R. M., & Nawa, H. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00325.x · Cited by 209
Huntington's disease: a synaptopathy?
Li, J.-Y., Plomann, M., & Brundin, P. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.08.006 · Cited by 208
Cells that Express Brain‐Derived Neurotrophic Factor mRNA in the Developing Postnatal Rat Brain
Friedman, W. J., Olson, L., & Persson, H. (1991) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1991.tb00854.x · Cited by 207
Wardle, R. A., & Poo, M.-M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08722.2003 · Cited by 201
Frerking, M., Malenka, R. C., & Nicoll, R. A. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.6.3383 · Cited by 201
Frank, L., Ventimiglia, R., Anderson, K., Lindsay, R. M., & Rudge, J. S. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01290.x · Cited by 199
Cloning and expression of a cDNA encoding a novel human neurotrophic factor
Kaisho, Y., Yoshimura, K., & Nakahama, K. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81536-w · Cited by 199
Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions
Frim, D. M., Uhler, T. A., Short, M. P., Ezzedine, Z. D., Klagsbrun, M., Breakefield, X. O., & Isacson, O. (1993) · NeuroReport · doi:10.1097/00001756-199304000-00006 · Cited by 199
Evolution of the vertebrate neurotrophin and Trk receptor gene families
Hallböök, F. (1999) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)00011-2 · Cited by 199
Momose, Y., Murata, M., Kobayashi, K., Tachikawa, M., Nakabayashi, Y., Kanazawa, I., & Toda, T. (2002) · Annals of Neurology · doi:10.1002/ana.10079 · Cited by 198
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery
Zuccato, C., Liber, D., Ramos, C., Tarditi, A., Rigamonti, D., Tartari, M., Valenza, M., & Cattaneo, E. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.01.001 · Cited by 196
Self-citationExpression of Normal and Mutant Huntingtin in the Developing Brain
Bhide, P. G., Day, M., Sapp, E., Schwarz, C., Sheth, A., Kim, J., Young, A. B., Penney, J., Golden, J., Aronin, N., et al. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-17-05523.1996 · Cited by 196
Carmichael, J., Sugars, K. L., Bao, Y. P., & Rubinsztein, D. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204861200 · Cited by 195
Katoh, R., Asano, T., Ueda, H., Morishita, R., Takeuchi, I. K., Inaguma, Y., & Kato, K. (2002) · The FASEB Journal · doi:10.1096/fj.02-0143fje · Cited by 193 · cited 1×
“Furthermore, memantine and riluzole (a non-competitive inhibitor of ionotropic glutamate NMDA receptor) (Marvanova et al., 2001; Mizuta et al., 2001; Katoh-Semba et al., 2002), and cystamine and cysteamine, have recently been shown to increase BDNF levels and their effects on HD have been analysed.”
BackgroundFusco, F. R., Chen, Q., Lamoreaux, W. J., Figueredo-Cardenas, G., Jiao, Y., Coffman, J. A., Surmeier, D. J., Honig, M. G., Carlock, L. R., & Reiner, A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01189.1999 · Cited by 191
Pérez‐Navarro, E., Canudas, A. M., Åkerud, P., Alberch, J., & Arenas, E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752190.x · Cited by 190
Brain‐derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice
Duan, W., Guo, Z., & Mattson, M. P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00071.x · Cited by 186
REST Repression of Neuronal Genes Requires Components of the hSWI·SNF Complex
Battaglioli, E., Andrés, M. E., Rose, D. W., Chenoweth, J. G., Rosenfeld, M. G., Anderson, M. E., & Mandel, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205691200 · Cited by 185
Lou, H., Kim, S.-K., Zaitsev, E., Snell, C. R., Lu, B., & Loh, Y. P. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.037 · Cited by 185
Duan, W., Lee, J., Guo, Z., & Mattson, M. P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:16:1:1 · Cited by 183
Hoffner, G., Kahlem, P., & Djian, P. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.5.941 · Cited by 180
Chuang, D.-M. (2004) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v16.i12.90 · Cited by 180
Cognitive disorders and neurogenesis deficits in Huntington’s disease mice are rescued by fluoxetine
Grote, H. E., Bull, N. D., Howard, M. L., Van Dellen, A., Blakemore, C., Bartlett, P. F., & Hannan, A. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04365.x · Cited by 179
Murer, M. G., Boissiere, F., Yan, Q., Hunot, S., Villares, J., Faucheux, B., Agid, Y., Hirsch, E., & Raisman-Vozari, R. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00219-x · Cited by 179
AAV-Mediated gene delivery of BDNF or GDNF is neuroprotective in a model of huntington disease
Kells, A. P., Fong, D. M., Dragunow, M., During, M. J., Young, D., & Connor, B. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.02.016 · Cited by 178
Cystamine Inhibits Caspase Activity
Lesort, M., Lee, M., Tucholski, J., & Johnson, G. V. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205812200 · Cited by 176
Lazic, S. E., Grote, H. E., Blakemore, C., Hannan, A. J., van Dellen, A., Phillips, W., & Barker, R. A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04715.x · Cited by 173
Ryu, J. K., Kim, J., Cho, S. J., Hatori, K., Nagai, A., Choi, H. B., Lee, M. C., McLarnon, J. G., & Kim, S. U. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.016 · Cited by 173
Diógenes, M. J., Fernandes, C. C., Sebastião, A. M., & Ribeiro, J. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4454-03.2004 · Cited by 172
Bachoud-Lévi, A.-C., Déglon, N., Nguyen, J.-P., Bloch, J., Bourdet, C., Winkel, L., Rémy, P., Goddard, M., Lefaucheur, J.-P., Brugières, P., et al. (2000) · Human Gene Therapy · doi:10.1089/10430340050111377 · Cited by 171
Castren, E., Thoenen, H., & Lindholm, D. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00386-j · Cited by 169
Katoh-Semba, R., Semba, R., Takeuchi, I. K., & Kato, K. (1998) · Neuroscience Research · doi:10.1016/s0168-0102(98)00040-6 · Cited by 168
Marvanová, M., Lakso, M., Pirhonen, J., Nawa, H., Wong, G., & Ċastrén, E. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1027 · Cited by 167
Cited by
Brain-derived neurotrophic factor in neurodegenerative diseases
Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947
Self-citationMolecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
“Biological and molecular findings have linked wild-type huntingtin to BDNF, a neurotrophin that is particularly important for the survival of striatal neurons and for the activity of the cortico-striatal synapses (668).”
BackgroundInfluentialSelf-citationPruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007) · Genomics · doi:10.1016/j.ygeno.2007.05.004 · Cited by 699
Ribeiro, J. A., & Sebastião, A. M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1379 · Cited by 577
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
“HD [202].”
Metadata
- Authors
- ZUCCATO, C., & CATTANEO, E.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 81
- Issue
- 5-6
- Pages
- 294-330
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2143935514
- Cited by
- 552
- References
- 341
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.